• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Plant-Based Soft Medical Robots

      Plant-Based Soft Medical Robots

      Magnetic Dressing Improves Diabetic Wound Healing

      Magnetic Dressing Improves Diabetic Wound Healing

      Eko’s Newest CORE 500 Stethoscope: A Review

      Eko’s Newest CORE 500 Stethoscope: A Review

      Microfluidic System Incorporates Eight Organ Tissues for Drug Testing

      Microfluidic System Incorporates Eight Organ Tissues for Drug Testing

    • Radiology
      Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

      Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Imaging Technique Reveals Living Brain Tissue in its Complexity

    • Cardiology
      Eko’s Newest CORE 500 Stethoscope: A Review

      Eko’s Newest CORE 500 Stethoscope: A Review

      Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

      Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      3D Printed Heart Muscle Beats

      3D Printed Heart Muscle Beats

    • Surgery
      Plant-Based Soft Medical Robots

      Plant-Based Soft Medical Robots

      Magnetic Dressing Improves Diabetic Wound Healing

      Magnetic Dressing Improves Diabetic Wound Healing

      Sensor Monitors Transplanted Organs for Signs of Rejection

      Sensor Monitors Transplanted Organs for Signs of Rejection

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

    • Nanomedicine
      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Stretchable E-Skin for Robotic Prostheses

      Stretchable E-Skin for Robotic Prostheses

      Glasses Provide Audible Prompts for Blind Wearers

      Glasses Provide Audible Prompts for Blind Wearers

      A Wearable to Manage Parkinson’s Motor Symptoms: Interview with Lucy Jung, CEO at Charco Neurotech

      A Wearable to Manage Parkinson’s Motor Symptoms: Interview with Lucy Jung, CEO at Charco Neurotech

      Robotic Ankle Helps with Postural Control in Amputees

      Robotic Ankle Helps with Postural Control in Amputees

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

A Pill to Replace Needles: Interview with Mir Imran, Chairman and CEO of Rani Therapeutics

July 5th, 2017 Conn Hastings Exclusive, Medicine, Oncology, Pediatrics

Operating within InCube Labs, a multi-disciplinary life sciences R&D lab based in Silicon Valley, Rani Therapeutics is developing a novel approach for the oral delivery of large-molecule drugs such as basal insulin, which is currently delivered via injections. By replacing painful injections with a painless, easy-to-take pill, the technology has the potential to drastically improve the lives of millions of patients suffering from diabetes, osteoporosis, rheumatoid arthritis, multiple sclerosis, and many other chronic conditions.

The idea is that the pill allows biological drugs, such as proteins, that would otherwise be destroyed in the stomach and intestine, to be delivered orally. This means that patients don’t have to undergo painful injections. For diabetic patients, who must inject insulin daily, this could mean that they don’t need to worry about needles and painful injections. The pill protects the drug inside itself until it reaches the intestine, where needles made of sugar emerge from the pill and inject the drug directly into the wall of the intestine.

Medgadget had the opportunity to ask Mir Imran, Chairman and CEO of Rani Therapeutics, some questions about the technology. Mir Imran is a prolific inventor of medical devices and has founded more than 20 life sciences companies. Mir holds more than 300 issued patents and is perhaps most well-known for his pioneering contributions to the first FDA-approved Automatic Implantable Cardioverter Defibrillator.

See the technology in action here:

 

Conn Hastings, Medgadget: Please introduce yourself and tell us a little about how you got into medical technology in general.

Mir Imran, Rani Therapeutics: My passion is developing and commercializing medical innovations. I have been an entrepreneur for the past 35 years, and my focus has been on solving major unmet clinical needs. I have a background in engineering and medicine, but even from a very young age, I loved to solve problems and understand how things worked. As a child in Hyderabad, India, I often took apart anything I could get my hands on to see how it worked. My mother eventually started buying toys for me in pairs — one to play with, the other to break down. At 8 years old, I made toys of wood, string and glue, and sold them to classmates. As a teenager, I took radio repair classes. I built AM radios, fit them inside matchboxes and sold them to friends. I later left India for the US and attended Rutgers, where I earned a BS in electrical engineering in 1976. By the time I actually had started my formal engineering training, I had probably a dozen years of hands-on experience.

As a college student, I had an experience that would change the course of my life and led me to the work I do today. I had a summer job working at The Matheney School for Cerebral Palsy Children. They needed engineers to develop communication devices for quadriplegic CP children, so I built a machine for one severely afflicted girl. The unit translated her facial expressions using pre-recorded phrases, allowing her to communicate. The experience was incredibly moving, and it inspired me to pursue medicine. After three years of med school, I decided that I did not want to be a doctor and instead wanted to pursue the business of innovation.

 

Medgadget: What inspired you to design the Rani device?

Mir Imran: Understanding and trying to solve big problems in medicine is what motivates me. Sometimes I discover problems through my own experience or from friends, and in other cases, I learn about problems through other sources. In the case of Rani, I heard from a friend in the world of big pharma that pharma companies spent billions of dollars over the past 40 years trying to convert injectable drugs into pills. And despite that kind of investment of time and money, the attempts were largely unsuccessful. This sounded like a juicy problem. If a solution could be developed, it would affect millions of patients and would have a major impact on the pharma market.

Take insulin as an example. As a protein-based drug, it cannot be ingested, only injected. With my engineering and medical background, I thought about it from a different perspective. If the pill could protect the drug until it reaches the intestine, and then inject the biologic into the intestinal wall — which has no sharp pain receptors — we could achieve successful administration without pain or loss of efficacy. While previous attempts to convert injections into pills have relied exclusively on chemistry, Rani has approached this challenge with engineering. That is the breakthrough.

 

Medgadget: Put simply, how does the technology work? What triggers the drug release in the intestine?

Mir Imran: The Rani pill is essentially a mini swallowable auto-injector that delivers the drug directly into the highly vascular intestinal wall, allowing the drug to be absorbed quickly into the bloodstream. Figuring out how to trigger the injection was a challenge. The answer came to me when I reached for an Alka Seltzer after a spicy Indian dinner. The reaction created in my glass gave me the idea to inflate a balloon and inject the needle. So, the patient swallows the pill, and it protects the proteins from breaking down in the digestive tract. When it reaches the intestine, the balloon inflates, prompting needles made of bioabsorbable materials — such as sugar — to be injected in the intestinal wall.

 

Medgadget: Is positioning in the intestine crucial, or can the pill consistently and reliably deliver the same drug payload? Are there any safety issues – could the pill block the intestine?

Mir Imran: The intestine offers an ideal location for optimal drug absorption into the bloodstream, and its lack of pain receptors make the approach painless. After the drug is administered, the sugar needle dissolves and the balloon and any other ingestible materials pass through and exit the body, without risk of blockage.

 

Medgadget: What types of drugs can be delivered using the pills? What diseases could these pills be useful for?

Mir Imran: The pill was designed with biologic drugs in mind, such as basal insulin, adalimumab, Human Interferon, and human growth hormone, each a multi-billion dollar market. Patients might recognize brand names, such as Humira® and Avonex®; these are examples of injectable biologics. We have partnered with two of the largest pharma companies — Novartis and AstraZeneca – to test their molecules on our platform. We are also testing a number of off-patent biologics.

 

Medgadget: Getting people to take drugs consistently is a challenge. Do you think that this pill could substantially enhance patient compliance for diseases where injections are currently needed?

Mir Imran: Certainly. Fear of needles is a major issue for patient compliance, and I saw recent estimates that non-compliance incurs costs $290 billion per year in complications and related hospitalizations.

Hundreds of millions of patients rely on biologic drugs, including people with diabetes, multiple sclerosis, and rheumatoid arthritis. We are talking about patient compliance and outcomes on a massive scale.

Let’s look at a specific example: there’s a basal insulin drug, Sanofi’s Lantus, which has been the historical market leader. About a year ago, Novo Nordisk came out with Tresiba, which was a longer acting insulin. In this case, the drug delivery innovation was a formulation change, causing the insulin to release over 42 hours, which resulted in patients experiencing fewer low blood sugar events between meals. Patients responded very quickly and enthusiastically when drug delivery reduced the frequency of these painful injections. Tresiba is on the way to a billion dollars in revenue within a year of marketing.

Now, imagine eliminating injections all together and delivering the drug through the oral route. This technology could be a game changer for pharma companies that license our technology. Because the market shifts happen very rapidly, partners could end up owning the market very quickly. For patients, this could mean they no longer have to fear or dread the treatment plans designed to help them.

Link: Rani Therapeutics…

Conn Hastings

Conn Hastings received a PhD from the Royal College of Surgeons in Ireland for his work in drug delivery, investigating the potential of injectable hydrogels to deliver cells, drugs and nanoparticles in the treatment of cancer and cardiovascular diseases. After achieving his PhD and completing a year of postdoctoral research, Conn pursued a career in academic publishing, before becoming a full-time science writer and editor, combining his experience within the biomedical sciences with his passion for written communication.

Sponsored
Ark Surgical Performs First Hysterectomies in the USA with its FDA-Cleared LapBox for Manual Morcellation

Ark Surgical Performs First Hysterectomies in the USA with its FDA-Cleared LapBox for Manual Morcellation

PACKAGING COMPLIANCE LABS WELCOMES NEW CFO, BERNADETTE LEGARETTA

PACKAGING COMPLIANCE LABS WELCOMES JENN GOFF, VP SALES, MARKETING, AND INNOVATION

Clarius Debuts its First Dual-Array Wireless Handheld Scanner Enabling Whole-Body Views of Superficial to Deep Anatomy

Clarius Debuts its First Dual-Array Wireless Handheld Scanner Enabling Whole-Body Views of Superficial to Deep Anatomy

National Liver Health Awareness Month Highlights the Urgent Need for Liver Disease Prevention

National Liver Health Awareness Month Highlights the Urgent Need for Liver Disease Prevention

interviews & reviews
A Wearable to Manage Parkinson’s Motor Symptoms: Interview with Lucy Jung, CEO at Charco Neurotech

A Wearable to Manage Parkinson’s Motor Symptoms: Interview with Lucy Jung, CEO at Charco Neurotech

Eko’s Newest CORE 500 Stethoscope: A Review

Eko’s Newest CORE 500 Stethoscope: A Review

Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!